Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04820764 · ClinicalTrials.gov registry record · NA

EFS of the CardioMech MVRS

A NA study of Mitral Regurgitation, sponsored by CardioMech AS.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
12
Study locations

NCT04820764 is a NA study of Mitral Regurgitation that is actively recruiting participants, run by CardioMech AS. The registered enrollment target is 25 participants, below the 1,023-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (98% lower). The trial reports 12 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04820764, a NA study of Mitral Regurgitation, is actively recruiting participants, sponsored by CardioMech AS.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
12
Study locations

Study Summary

Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

Conditions Studied

Interventions

  • DEVICE CardioMech MVRS

Study Locations (12)

Minnesota

  • Mayo Clinic - Rochester
  • CentraCare Heart & Vascular Center - Saint Cloud

Ohio

  • The Christ Hospital - Cincinnati
  • Cleveland Clinic - Cleveland

California

  • Cardiovascular Institute of Los Robles Health System - Thousand Oaks

Illinois

  • Northwestern University - Evanston

Kansas

  • Ascension St. Francis via Christi - Wichita

New York

  • NYU Langone - New York

North Carolina

  • Atrium Health Sanger Heart and Vascular Institute - Charlotte

Tennessee

  • Ascension St. Thomas West - Nashville

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-07-27
Est. Completion 2031-09
Phase NA

Sponsor

CardioMech AS

1 total trials

What the Registry Record Tells You About NCT04820764

The ClinicalTrials.gov registry entry for NCT04820764 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,023-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (98% lower). The listed sponsor is CardioMech AS, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mitral Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which CardioMech MVRS is the first listed.

NCT04820764 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Minnesota, Ohio, California.

Frequently Asked Questions

What is clinical trial NCT04820764 about?

NCT04820764 is a clinical study titled "EFS of the CardioMech MVRS". Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

What is the current status of trial NCT04820764?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-07-27. Estimated completion is 2031-09.

What conditions does trial NCT04820764 study?

This clinical trial studies the following conditions: Mitral Regurgitation.

What interventions are being tested in trial NCT04820764?

The interventions under investigation include: CardioMech MVRS (DEVICE).

Who is sponsoring clinical trial NCT04820764?

This trial is sponsored by CardioMech AS, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04820764 being conducted?

This trial has 12 study locations across California, Illinois, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mitral Regurgitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.